Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Candidates can click on the link provided here to download the official notice related to the CBSE Class 10th and 12th rescheduling of exams.Schools have been instructed to communicate the revised ...

RBSE released the Class 12th Exam 2026 date sheet at rajeduboard.rajasthan.gov.in. Theory exams will take place from February 12 to March 11, 2026. Exams will be held in a single morning shift.

CBSE Class 12 English (Core) Deleted Syllabus 2025: The Central Board of Secondary Education (CBSE), a national-level board of education in India, has revised its curriculum. This article details the ...

The CBSE Class 12 Chemistry Board Exam is scheduled to be held on February 28, 2026. With just one month left for the examination, the final 30 days become extremely crucial for students aiming to ...

CBSE Class 12 Chemistry is a crucial subject that requires strong conceptual clarity and regular practice to score well in ...

The Central Board of Secondary Education(CBSE) will conduct the Senior School Certificate Examinations (Class 12th Board Exam) from February 17 to April 9, 2026. The board exams will commence on ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...